<DOC>
	<DOCNO>NCT00553748</DOCNO>
	<brief_summary>This ten subject , phase 1 study . The purpose Phase 1 study demonstrate drug safety target group subject high grade brain cancer . This population represent potential clinical population may benefit PET image tracer . The study also begin collection baseline image data allow u gain information improve design conduct future trial .</brief_summary>
	<brief_title>Phase I , Open Label , Single Center Safety Study F-18FLT</brief_title>
	<detailed_description>This ten subject , phase 1 study . The purpose study demonstrate drug safety group high grade brain tumor evaluate cell proliferation F-18 FLT . FLT known clear normal brain detect brain tumor . This population represent potential clinical population may benefit PET image tracer . This information help improve design conduct future F-18 FLT clinical trial .</detailed_description>
	<mesh_term>Brain Neoplasms</mesh_term>
	<criteria>Subject may male female race / ethnicity ; At time study drug dosing , subject reach 18th birthday ; Subject histologic diagnosis one follow malignancy glioblastoma gliosarcoma , anaplastic mixed/anaplastic oligodendroglioma ( anaplastic ) astrocytoma lesion visible CT MR minimum histological grade III/IV ; Subject suspect radiation necrosis plan resection ; Subject subject 's legally acceptable representative provide informed consent ; Subject capable complying study procedure able lie still PET scanner ; Subject capable communicating study personnel ; Subject adequate liver kidney function Subject pregnant nursing ; Subject anemic ( defined hemoglobin level &lt; 10 ) ; Subject receive chemotherapy radiation therapy within two week prior image . Subject reflect serum liver enzyme outside normal laboratory reference range ; Subject history chronic liver disease , may compromise liver function ; Subject kidney disease reflect serum creatinine outside normal laboratory reference range ; Subject prior history stroke condition head neck , investigator 's opinion , might affect circulation brain image interpretation ( example include , limited , previous stroke cystic soften cerebral deformity , arteriovenous malformation ) ; Subject history significant cerebrovascular disease ; Subject condition personal circumstance , judgment investigator , might interfere collection complete good quality data Subject previously receive [ F18 ] FLT time , investigational product within past two week .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2008</verification_date>
</DOC>